Mesenchymal stem cell-based therapy

Vaibhav Mundra, Ivan C. Gerling, Ram I. Mahato

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Mesenchymal stem cells (MSCs) are multipotent adult stem cells which have self-renewal capacity and differentiation potential into several mesenchymal lineages including bones, cartilages, adipose tissues and tendons. MSCs may repair tissue injuries and prevent immune cell activation and proliferation. Immunomodulation and secretion of growth factors by MSCs have led to realizing the true potential of MSC-based cell therapy. The use of MSCs as immunomodulators has been explored in cell/organ transplant, tissue repair, autoimmune diseases, and prevention of graft vs host disease (GVHD). This review focuses on the clinical applications of MSC-based cell therapy, with particular emphasis on islet transplantation for treating type I diabetes.

Original languageEnglish (US)
Pages (from-to)77-89
Number of pages13
JournalMolecular Pharmaceutics
Volume10
Issue number1
DOIs
StatePublished - Jan 7 2013

Fingerprint

Cell- and Tissue-Based Therapy
Mesenchymal Stromal Cells
Multipotent Stem Cells
Transplants
Islets of Langerhans Transplantation
Adult Stem Cells
Immunomodulation
Immunologic Factors
Graft vs Host Disease
Type 1 Diabetes Mellitus
Tendons
Autoimmune Diseases
Cartilage
Adipose Tissue
Intercellular Signaling Peptides and Proteins
Cell Proliferation
Bone and Bones
Wounds and Injuries

Keywords

  • biomaterials
  • gene delivery
  • immunomodulation
  • islet transplantation
  • mesenchymal stem cells

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery

Cite this

Mesenchymal stem cell-based therapy. / Mundra, Vaibhav; Gerling, Ivan C.; Mahato, Ram I.

In: Molecular Pharmaceutics, Vol. 10, No. 1, 07.01.2013, p. 77-89.

Research output: Contribution to journalArticle

Mundra, Vaibhav ; Gerling, Ivan C. ; Mahato, Ram I. / Mesenchymal stem cell-based therapy. In: Molecular Pharmaceutics. 2013 ; Vol. 10, No. 1. pp. 77-89.
@article{d68238dd57814ae1b58b18eb2663702a,
title = "Mesenchymal stem cell-based therapy",
abstract = "Mesenchymal stem cells (MSCs) are multipotent adult stem cells which have self-renewal capacity and differentiation potential into several mesenchymal lineages including bones, cartilages, adipose tissues and tendons. MSCs may repair tissue injuries and prevent immune cell activation and proliferation. Immunomodulation and secretion of growth factors by MSCs have led to realizing the true potential of MSC-based cell therapy. The use of MSCs as immunomodulators has been explored in cell/organ transplant, tissue repair, autoimmune diseases, and prevention of graft vs host disease (GVHD). This review focuses on the clinical applications of MSC-based cell therapy, with particular emphasis on islet transplantation for treating type I diabetes.",
keywords = "biomaterials, gene delivery, immunomodulation, islet transplantation, mesenchymal stem cells",
author = "Vaibhav Mundra and Gerling, {Ivan C.} and Mahato, {Ram I.}",
year = "2013",
month = "1",
day = "7",
doi = "10.1021/mp3005148",
language = "English (US)",
volume = "10",
pages = "77--89",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "1",

}

TY - JOUR

T1 - Mesenchymal stem cell-based therapy

AU - Mundra, Vaibhav

AU - Gerling, Ivan C.

AU - Mahato, Ram I.

PY - 2013/1/7

Y1 - 2013/1/7

N2 - Mesenchymal stem cells (MSCs) are multipotent adult stem cells which have self-renewal capacity and differentiation potential into several mesenchymal lineages including bones, cartilages, adipose tissues and tendons. MSCs may repair tissue injuries and prevent immune cell activation and proliferation. Immunomodulation and secretion of growth factors by MSCs have led to realizing the true potential of MSC-based cell therapy. The use of MSCs as immunomodulators has been explored in cell/organ transplant, tissue repair, autoimmune diseases, and prevention of graft vs host disease (GVHD). This review focuses on the clinical applications of MSC-based cell therapy, with particular emphasis on islet transplantation for treating type I diabetes.

AB - Mesenchymal stem cells (MSCs) are multipotent adult stem cells which have self-renewal capacity and differentiation potential into several mesenchymal lineages including bones, cartilages, adipose tissues and tendons. MSCs may repair tissue injuries and prevent immune cell activation and proliferation. Immunomodulation and secretion of growth factors by MSCs have led to realizing the true potential of MSC-based cell therapy. The use of MSCs as immunomodulators has been explored in cell/organ transplant, tissue repair, autoimmune diseases, and prevention of graft vs host disease (GVHD). This review focuses on the clinical applications of MSC-based cell therapy, with particular emphasis on islet transplantation for treating type I diabetes.

KW - biomaterials

KW - gene delivery

KW - immunomodulation

KW - islet transplantation

KW - mesenchymal stem cells

UR - http://www.scopus.com/inward/record.url?scp=84872139117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872139117&partnerID=8YFLogxK

U2 - 10.1021/mp3005148

DO - 10.1021/mp3005148

M3 - Article

C2 - 23215004

AN - SCOPUS:84872139117

VL - 10

SP - 77

EP - 89

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 1

ER -